- The trend backdrop is active with a 6-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
BAX
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Baxter International Inc. · Healthcare · Medical Instruments & Supplies
Latest close
23.56 EUR
3.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 37.1% above the Trend Line and sits at 90.0% of its 52-week range. The latest completed week returned 3.9%, after a 19.3% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.
Setup score
57
out of 100
Latest Close
23.56 EUR
7 Aug 2026
1W Return
3.9%
latest completed week
4W Return
19.3%
short-term follow-through
12W Return
57.2%
quarterly tape
Trend Breadth
11.5%
6 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 41.90% based on similar historical setup states.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.9%
Latest completed week; four-week move 19.3%.
Indicator stack
27/75
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.90%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
10 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 37.1% above the Trend Line and sits at 90.0% of its 52-week range. The latest completed week returned 3.9%, after a 19.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7012-week average 0.31
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.70Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 19.3% over four weeks, 57.2% over 12 weeks, and 17.4% over one year. The current trend has remained active for 6 consecutive weeks.
Performance by holding period
Active trend streak6 weeks
Active weeks in one year6
Trend breadth11.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.41Latest activity-pressure read.
Pressure change-1.8%Four-week change in activity pressure.
Leadership8.71Latest relative-leadership reading.
RS change190.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 10 relevant articles.
2 positive · 7 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.4%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+14.4%Week of 31 Jul.
Worst week-10.9%Week of 6 Mar.
Latest week+3.9%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains6
Flat weeks0
Modest losses10
Sharp losses3
Recent vol5.1%13-week weekly-return volatility.
Base vol5.6%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank4 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Instruments & Supplies
4-week rank2 / 18
Group average3.2%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD83.3%positive activity pressure
RS11.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis56/100Latest 12-week confirmation: trend 6/12, activity pressure 11/12, relative leadership 2/12.
Activity pressure 0.70; No reversal markers Next-Week ExpectancyNegative 41.90%Next-week expectancy is negative with a 41.90% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 10 relevant articles.
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Reduce" by Analysts Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 23.56 EUR | 3.9% | 17.18 EUR | 26.54 EUR | 1.41 | 8.71 | 251 | On |
| 31 Jul 2026 | 22.67 EUR | 14.4% | 16.99 EUR | 26.62 EUR | 1.45 | 7.31 | 2.6K | On |
| 24 Jul 2026 | 19.83 EUR | -1.5% | 16.79 EUR | 26.72 EUR | 1.42 | -6.47 | 0 | On |
| 17 Jul 2026 | 20.13 EUR | 1.9% | 16.66 EUR | 26.84 EUR | 1.48 | -4.95 | 1.5K | On |
| 10 Jul 2026 | 19.75 EUR | -0.3% | 16.53 EUR | 26.98 EUR | 1.44 | -9.60 | 719 | On |
| 3 Jul 2026 | 19.80 EUR | 2.2% | 16.42 EUR | 27.10 EUR | 1.41 | -11.65 | 0 | On |
| 26 Jun 2026 | 19.36 EUR | 11.7% | 16.30 EUR | 27.22 EUR | 1.34 | -12.87 | 0 | Off |
| 19 Jun 2026 | 17.33 EUR | -2.8% | 16.19 EUR | 27.35 EUR | 1.09 | -24.64 | 0 | Off |
| 12 Jun 2026 | 17.83 EUR | 5.0% | 16.14 EUR | 27.48 EUR | 0.91 | -20.55 | 0 | Off |
| 5 Jun 2026 | 16.98 EUR | 4.2% | 16.07 EUR | 27.61 EUR | 0.47 | -23.54 | 100 | Off |
| 29 May 2026 | 16.30 EUR | -1.3% | 16.02 EUR | 27.74 EUR | 0.09 | -28.54 | 0 | Off |
| 22 May 2026 | 16.51 EUR | 10.1% | 16.02 EUR | 27.86 EUR | -0.01 | -26.88 | 313 | Off |
| 15 May 2026 | 14.99 EUR | 1.8% | 16.13 EUR | 27.99 EUR | -0.21 | -33.30 | 0 | Off |
| 8 May 2026 | 14.73 EUR | -2.7% | 16.28 EUR | 28.13 EUR | -0.16 | -35.92 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.